94 related articles for article (PubMed ID: 28231062)
1. Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population.
Adehin A; Bolaji OO; Maggo S; Kennedy MA
Drug Metab Pers Ther; 2017 Mar; 32(1):39-47. PubMed ID: 28231062
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population.
Adehin A; Bolaji OO
Drug Metab Pers Ther; 2015 Sep; 30(3):203-10. PubMed ID: 26098700
[TBL] [Abstract][Full Text] [Related]
3. Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers.
Begas E; Tsioutsiouliti A; Kouvaras E; Haroutounian SA; Kasiotis KM; Kouretas D; Asprodini E
Food Chem Toxicol; 2017 Feb; 100():80-89. PubMed ID: 28011360
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.
Mochizuki J; Murakami S; Sanjo A; Takagi I; Akizuki S; Ohnishi A
J Gastroenterol Hepatol; 2005 Aug; 20(8):1191-7. PubMed ID: 16048566
[TBL] [Abstract][Full Text] [Related]
5. Five genetic polymorphisms of cytochrome P450 enzymes in the Czech non-Roma and Czech Roma population samples.
Dlouhá L; Adámková V; Šedová L; Olišarová V; Hubáček JA; Tóthová V
Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681777
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
Bilgen T; Tosun O; Luleci G; Keser I
Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Belmonte C; Román M; Vieira de Lara D; Zubiaur P; Koller D; Mejía G; Abad-Santos F
J Psychopharmacol; 2019 Apr; 33(4):522-531. PubMed ID: 30789308
[TBL] [Abstract][Full Text] [Related]
9. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test.
Saruwatari J; Nakagawa K; Shindo J; Tajiri T; Fujieda M; Yamazaki H; Kamataki T; Ishizaki T
Clin Pharmacol Ther; 2002 Aug; 72(2):200-8. PubMed ID: 12189367
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Xenobiotic-Metabolizing Enzyme Activities across Menstrual Cycle in Healthy Volunteers.
Asprodini E; Tsiokou V; Begas E; Kilindris T; Kouvaras E; Samara M; Messinis I
J Pharmacol Exp Ther; 2019 Feb; 368(2):262-271. PubMed ID: 30591530
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
[TBL] [Abstract][Full Text] [Related]
13. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2003 Mar; 55(3):321-4. PubMed ID: 12630986
[TBL] [Abstract][Full Text] [Related]
14. Water pipe (Shisha, Hookah, Arghile) Smoking and Secondhand Tobacco Smoke Effects on CYP1A2 and CYP2A6 Phenotypes as Measured by Caffeine Urine Test.
Yılmaz ŞG; Llerena A; De Andrés F; Karakaş Ü; Gündoğar H; Erciyas K; Kimyon S; Mete A; Güngör K; Özdemir V
OMICS; 2017 Mar; 21(3):177-182. PubMed ID: 28253085
[TBL] [Abstract][Full Text] [Related]
15. High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.
Aklillu E; Djordjevic N; Carrillo JA; Makonnen E; Bertilsson L; Ingelman-Sundberg M
OMICS; 2014 Jul; 18(7):446-53. PubMed ID: 24380444
[TBL] [Abstract][Full Text] [Related]
16. From Genotype to Phenotype: Content and Activities of Cytochromes P450 2A6 in Human Liver In Vitro and Predicted In Vivo.
Fang Y; Wang T; Guo YY; Zhang HF; Wen Q; Xing YR; Gao N; Qiao HL
J Pharmacol Exp Ther; 2020 Mar; 372(3):320-330. PubMed ID: 31882454
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the impact of CYP1A2 induction by charbroiled meal on metabolic phenotype.
Anumu George J; Adehin A; Bolaji OO
Clin Nutr ESPEN; 2018 Oct; 27():96-99. PubMed ID: 30144900
[TBL] [Abstract][Full Text] [Related]
18. CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study.
Moonen HJ; Moonen EJ; Maas L; Dallinga JW; Kleinjans JC; de Kok TM
Food Chem Toxicol; 2004 Jun; 42(6):869-78. PubMed ID: 15110095
[TBL] [Abstract][Full Text] [Related]
19. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
[TBL] [Abstract][Full Text] [Related]
20. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
Skarke C; Kirchhof A; Geisslinger G; Lötsch J
Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
